They are rare tumors that arise from the hormone-producing cells of the pancreas. These tumors are usually slow-growing and can secrete hormones, leading to elevated hormone levels. There are several specific subtypes among the hormone-producing types. Treatment options vary depending on the size of the tumor, its spread, and whether it produces hormones.
Types of Pancreatic Endocrine Tumors
P are rare types of cancer that originate from the hormone-producing cells of the pancreas. These tumors are usually called pancreatic neuroendocrine tumors (PNETs). They develop from the hormone-secreting endocrine cells of the pancreas. The pancreas is an organ that has both endocrine and exocrine functions. However, endocrine tumors have a different structure because they originate from hormone-secreting cells.
Pancreatic endocrine tumors are divided into two main types: functional and non-functional. Functional tumors, secrete hormones and often cause symptoms related to the overproduction of these hormones. The most common types of functional tumors include insulinoma, glucagonoma, gastrinoma, somatostatinoma, and VIPoma. For example, insulinomas cause overproduction of insulin, leading to hypoglycemia. Gastrinomas produce excess gastrin and may increase stomach acid secretion, leading to ulcer development.
Non-functional tumors They do not produce hormones or do not show symptoms even if they do. For this reason, these tumors are usually diagnosed late because they do not show symptoms. As non-functional tumors grow, they can put pressure on surrounding tissues and cause mechanical symptoms such as pain and jaundice.
Treatment options vary depending on the type, size, and spread of the tumor, and the patient's overall health. Surgery is the first choice for tumor removal. However, in advanced cases, chemotherapy, targeted therapies, or hormone therapy may be used. Early diagnosis is critical to successful treatment.
Pancreatic neuroendocrine tumors, although rare, are associated with a genetic predisposition. Inherited syndromes such as MEN1 (Multiple Endocrine Neoplasia Type 1) may increase the risk of developing these tumors.
Diagnosis of Pancreatic Endocrine Tumor
PNET is usually diagnosed based on the patient's symptoms, blood tests, imaging techniques, and biopsy. Since these tumors can be functional or non-functional, the diagnostic process can vary.
Functional tumors, presents distinct symptoms related to hormone production. Therefore, it is usually easier to reach a diagnosis.
Blood tests, plays an important role in the diagnosis of pancreatic endocrine tumors. Measuring hormone levels in the patient's blood helps understand whether the tumor secretes hormones.
Imaging techniques, is used to determine the location and size of the tumor. Methods such as CT, MRI and positron emission tomography (PET) are preferred for this purpose. Nuclear medicine methods can also be used to specifically identify PNETs.
Biopsy, is necessary to confirm the diagnosis and determine whether the tumor is malignant. Tissue samples taken by fine needle aspiration or surgical biopsy are subjected to pathology. In this way, the type and degree of the tumor are determined. Using all these methods together allows an accurate and definitive diagnosis to be made.
Pancreatic Endocrine Tumor Treatment Methods
PNET treatment options vary depending on factors such as the type of tumor, its size, spread, and the patient's overall health. Treatments include surgery, drug therapies, targeted therapy, and radiation therapy.
Surgical, is considered the most effective method in the treatment of PNET. If the tumor is diagnosed in an early stage, complete removal of the tumor may be possible. Surgical intervention is important to control hormone-secreting tumors, especially functional tumors.
In cases where surgery is not possible or the tumor has spread, drug treatments comes into play. Somatostatin analogs, are used to control the symptoms of hormone-secreting tumors. These drugs can also slow the growth of the tumor. In addition, targeted therapies plays an important role as well. For example, drugs such as sunitinib and everolimus are used as molecular therapy options that target tumor growth.
Chemotherapy, may be preferred in more advanced stages or aggressive tumors. Especially in tumors that have spread or metastasized, chemotherapy is used to prevent the growth and spread of tumor cells. Drugs such as streptozotocin and doxorubicin are commonly used agents in chemotherapy.
Radiotherapy, can usually be used for palliative purposes in advanced stages of the disease. Additionally, in the field of nuclear medicine, PRRT binds to somatostatin receptors. Thus, it can be used as a treatment option to target tumors.
In conclusion, a multidisciplinary approach is applied in the treatment of PNET. A personalized treatment plan is created by considering the patient's condition. With early diagnosis and correct treatment options, the life expectancy and quality of life of patients can be increased.
English
